SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20882878
Source:
http://linkedlifedata.com/resource/pubmed/id/20882878
Search
Subject
(
52
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008838
,
umls-concept:C0087111
,
umls-concept:C1336219
,
umls-concept:C1559154
,
umls-concept:C1655731
pubmed:issue
4
pubmed:dateCreated
2010-10-1
pubmed:abstractText
This trial aimed to evaluate the safety and efficacy of epigenetic therapy associated with cisplatin chemoradiation in FIGO Stage IIIB patients.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8100357
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Hydralazine
,
http://linkedlifedata.com/resource/pubmed/chemical/Valproic Acid
pubmed:status
MEDLINE
pubmed:issn
0392-2936
pubmed:author
pubmed-author:AriasDD
,
pubmed-author:CandelariaMM
,
pubmed-author:CetinaLL
,
pubmed-author:ChanonaJJ
,
pubmed-author:Dueñas-GonzálezAA
,
pubmed-author:González-FierroAA
,
pubmed-author:Pérez-CárdenasEE
,
pubmed-author:Taja-ChayebLL
,
pubmed-author:Trejo-BecerrilCC
,
pubmed-author:de la Cruz-HernándezEE
pubmed:issnType
Print
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
386-91
pubmed:meshHeading
pubmed-meshheading:20882878-Adult
,
pubmed-meshheading:20882878-Aged
,
pubmed-meshheading:20882878-Antineoplastic Agents
,
pubmed-meshheading:20882878-Brachytherapy
,
pubmed-meshheading:20882878-Cisplatin
,
pubmed-meshheading:20882878-Combined Modality Therapy
,
pubmed-meshheading:20882878-Epigenesis, Genetic
,
pubmed-meshheading:20882878-Female
,
pubmed-meshheading:20882878-Humans
,
pubmed-meshheading:20882878-Hydralazine
,
pubmed-meshheading:20882878-Middle Aged
,
pubmed-meshheading:20882878-Neoplasm Staging
,
pubmed-meshheading:20882878-Uterine Cervical Neoplasms
,
pubmed-meshheading:20882878-Valproic Acid
pubmed:year
2010
pubmed:articleTitle
Epigenetic therapy and cisplatin chemoradiation in FIGO stage IIIB cervical cancer.
pubmed:affiliation
Unidad de Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas (IIB), Universidad Nacional Autonóma de Mexico (UNAM), Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't